Related Experiment Videos

Excess intravascular coagulation complicating low cardiac output

Insights

Children with congenital heart disease undergoing cardiopulmonary bypass surgery showed improved coagulation factors post-surgery. However, those who died experienced worsening coagulation, linked to low body temperature and poor perfusion.

Area of Science:

  • Pediatric Cardiology
  • Hematology
  • Cardiovascular Surgery

Background:

  • Congenital heart disease (CHD) presents complex challenges in pediatric surgical care.
  • Cardiopulmonary bypass (CPB) surgery is a critical intervention for many children with CHD.
  • Coagulation disturbances are a known complication following CPB.

Purpose of the Study:

  • To investigate serial coagulation factor levels in children with CHD during the early postoperative period after CPB.
  • To identify factors associated with adverse coagulation profiles in these patients.
  • To evaluate the potential benefit of fresh frozen plasma (FFP) in managing coagulation abnormalities.

Main Methods:

  • Serial measurement of coagulation factor levels in 42 children undergoing CPB for CHD within the first 20 hours post-surgery.
  • Categorization of patients into acyanotic, surviving cyanotic, and non-surviving cyanotic groups.
  • Correlation analysis of coagulation profiles with clinical parameters like skin temperature, blood loss, and cardiac output.

Main Results:

  • Acyanotic and surviving cyanotic patients demonstrated progressive improvement in coagulation profiles.
  • Twelve cyanotic patients who did not survive showed persistently low or declining coagulation factor levels.
  • Coagulation abnormalities correlated significantly with hypothermia and increased blood loss, suggesting intravascular coagulation due to low cardiac output and poor perfusion.
  • FFP administration in eight non-surviving patients showed no apparent benefit.

Conclusions:

  • Postoperative coagulation profiles in pediatric CPB patients are indicative of outcomes.
  • Hypothermia and poor tissue perfusion are significant contributors to coagulopathy after CPB in CHD.
  • Excessive intravascular coagulation appears to be a key mechanism underlying these adverse events.

Related Concept Videos